Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Urinary Symptoms in Spinal Cord Injury and Spina Bifida
NCT02748317Phase 2Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Jan 2016
- Primary completion
- Oct 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in lower urinary tract symptoms (LUTS), urinary tract infection (UTI), sponsored by MedStar Health Research Institute. Started Jan 2016; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
lower urinary tract symptoms (LUTS)urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02748317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748317.